No Data
No Data
Express News | The latest research roadmap from the Institutions has been released, with Farasis Energy (Gan Zhou) Co., Ltd. being the most focused upon.
Canature Health Technology (300272.SZ) plans to distribute a mid-term profit allocation of 0.7 yuan for every 10 shares in the second distribution of 2024.
Canature Health Technology (300272.SZ) disclosed the second mid-term profit distribution plan for 2024, the company intends to distribute... for every 10 shares...
Canature Health Technology (300272.SZ): Overseas income generally accounts for about 65% of total annual revenue.
Gelonghui November 15th | canature health technology (300272.SZ) stated during an investor survey on November 15, 2024, that overseas income generally accounts for about 65% of the total annual income. Currently, the company has already reached brand production agreements or sales framework agreements with many long-term important customers overseas, and is expected to continue to play a synergistic role, supporting the continuous improvement of market share in overseas markets.
canature health technology (300272): Overseas revenue contributes to the basic level of performance, which is affected by the losses of its subsidiaries.
The company's income performance fell short of expectations. canature health technology achieved revenue of 1.254 billion yuan in Q1-3 2024, a year-on-year increase of 1%; achieved net income attributable to the mother of 0.084 billion yuan, a year-on-year decrease of 35%; achieved non-net profit attributable to the mother of 0.81 billion yuan.
Canature Health Technology (300272): Operations stable, non-operational drag on performance.
Event overview The company released the third quarter report of 2024: 24Q1-Q3: total operating income of 1.254 billion yuan (YOY +1.00%), net income attributable to the parent company of 0.084 billion yuan (YOY-34.92%), after deducting non-recurring items.
Kaineng Health: Report for the third quarter of 2024
No Data